Document Detail


Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
MedLine Citation:
PMID:  12200607     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: the changes in lung function following surfactant treatment can only be explained by initial stabilisation of already aerated alveoli followed by recruitment of new gas exchange units as mechanisms involved in mediating the effect of surfactant on gas exchange. However, since no significant correlation between changes in functional residual capacity and improvement in arterial-to-alveolar oxygen tension ratio was seen, other effects of surfactant must be considered. These include local and/or systemic changes in haemodynamics.
Authors:
Jürgen Dinger; Andreas Töpfer; Peter Schaller; Roland Schwarze
Related Documents :
1955967 - Congenital nasolacrimal sac mucocele associated with respiratory distress.
18786867 - Inverse coupling between respiratory and cardiac oscillators in a life-threatening even...
8545167 - Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bron...
19399007 - Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with s...
10447137 - Utilization of supplemental iron by premature infants fed fortified human milk.
12760517 - Pattern induction by infant language learners.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article     Date:  2002-07-12
Journal Detail:
Title:  European journal of pediatrics     Volume:  161     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-08-29     Completed Date:  2003-03-04     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  485-90     Citation Subset:  IM    
Affiliation:
Klinik für Kinderheilkunde, Medizinische Fakultät, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany. Dinger@ukd80.med.tu-dresden.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Functional Residual Capacity* / drug effects
Hemodynamics
Humans
Infant, Newborn
Infant, Premature*
Lung / drug effects*,  physiology
Lung Compliance / drug effects
Male
Pulmonary Gas Exchange / drug effects
Pulmonary Surfactants / administration & dosage,  therapeutic use*
Respiratory Distress Syndrome, Newborn / drug therapy*,  physiopathology
Time Factors
Chemical
Reg. No./Substance:
0/Pulmonary Surfactants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new case of autosomal recessive agammaglobulinaemia with impaired pre-B cell differentiation due t...
Next Document:  Severe Coxsackie virus B infection in preterm newborns treated with pleconaril.